thyssenkrupp nucera AG & Co. KGaA

WBAG:NCH2 Stock Report

Market Cap: €1.1b

thyssenkrupp nucera KGaA Valuation

Is NCH2 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of NCH2 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: NCH2 (€8.43) is trading above our estimate of fair value (€3.28)

Significantly Below Fair Value: NCH2 is trading above our estimate of fair value.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for NCH2?

Key metric: As NCH2 is barely profitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for NCH2. This is calculated by dividing NCH2's market cap by their current revenue.
What is NCH2's PS Ratio?
PS Ratio1.4x
Sales€771.40m
Market Cap€1.07b

Price to Sales Ratio vs Peers

How does NCH2's PS Ratio compare to its peers?

The above table shows the PS ratio for NCH2 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average0.2x
POS PORR
0.1x2.6%€617.0m
STR Strabag
0.3x2.4%€4.6b
HST Hutter & Schrantz Stahlbau
0.3xn/a€29.2m
SWUT SW Umwelttechnik Stoiser & Wolschner
0.2xn/a€28.3m
NCH2 thyssenkrupp nucera KGaA
1.4x14.5%€1.1b

Price-To-Sales vs Peers: NCH2 is expensive based on its Price-To-Sales Ratio (1.4x) compared to the peer average (0.2x).


Price to Sales Ratio vs Industry

How does NCH2's PS Ratio compare vs other companies in the European Construction Industry?

11 CompaniesPrice / SalesEstimated GrowthMarket Cap
NCH2 1.4xIndustry Avg. 0.4xNo. of Companies30PS00.40.81.21.62+
11 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: NCH2 is expensive based on its Price-To-Sales Ratio (1.4x) compared to the European Construction industry average (0.4x).


Price to Sales Ratio vs Fair Ratio

What is NCH2's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

NCH2 PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio1.4x
Fair PS Ratio0.2x

Price-To-Sales vs Fair Ratio: NCH2 is expensive based on its Price-To-Sales Ratio (1.4x) compared to the estimated Fair Price-To-Sales Ratio (0.2x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst NCH2 forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current€8.43
€14.71
+74.6%
34.8%€25.50€8.50n/a11
Nov ’25€9.57
€14.71
+53.7%
34.8%€25.50€8.50n/a11
Oct ’25€9.51
€14.71
+54.7%
34.8%€25.50€8.50n/a11
Sep ’25€9.26
€15.35
+65.8%
38.3%€25.50€8.50n/a11
Aug ’25€8.55
€17.40
+103.6%
35.3%€25.50€9.00n/a12
Jul ’25€9.24
€18.96
+105.3%
26.1%€25.50€10.00n/a12
Jun ’25€11.58
€18.96
+63.7%
26.1%€25.50€10.00n/a12
May ’25€12.08
€21.62
+79.0%
21.4%€27.00€11.00n/a11
Apr ’25€14.40
€21.80
+51.4%
22.3%€29.00€11.00n/a11
Mar ’25€15.40
€22.40
+45.5%
21.4%€29.00€12.00n/a12
Feb ’25€14.95
€24.03
+60.7%
16.4%€29.00€16.00n/a10
Jan ’25€18.34
€24.03
+31.0%
16.4%€29.00€16.00n/a10
Dec ’24€16.47
€18.50
+12.3%
13.5%€21.00€16.00n/a2

Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.


Discover undervalued companies